Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbara Shreve Briggs is active.

Publication


Featured researches published by Barbara Shreve Briggs.


Tetrahedron Letters | 1991

Enantioselective acylation of a beta-lactam intermediate in the synthesis of loracarbef using penicillin G amidase

Milton J. Zmijewski; Barbara Shreve Briggs; Allen R. Thompson; Ian G. Wright

Penicillin G amidase from E. coli has been shown to selectively acylate, in an efficient manner, the (2R,3S) isomer of a cis, racemic azetidinone intermediate used in a synthesis of loracarbef, a carbacephalosporin antibiotic. The acylation occurs using methyl phenylacetate (MPA) and using methyl phenoxyacetate (MPOA) as the acylating agents. The enzyme displays similar enantioselectivity with MPOA or MPA.


Tetrahedron Letters | 1998

Bioreduction of (R)-carvone and regioselective Baeyer-Villiger oxidations: Application to the asymmetric synthesis of cryptophycin fragment A

David L. Varie; John Brennan; Barbara Shreve Briggs; Jason S. Cronin; David A. Hay; John Allan Rieck; Milton Joseph Zmijewski

Abstract Cryptophycin fragment A ( 1 ) was prepared in high enantiomeric purity in 10 steps from ( R )-carvone. A stereoselective bioreduction of ( R )-carvone to neodihydrocarveol and a regioselective Baeyer-Villiger oxidation of cyclohexanone 8 with pertrifluoroacetic acid were employed in this synthesis.


Biotechnology Letters | 1996

o-Phthalyl amidase in the synthesis of loracarbef: Process development using this novel biocatalyst

Thomas D. Black; Barbara Shreve Briggs; Robert S. Evans; William L. Muth; Surya Vangala; Milton Joseph Zmijewski

SummaryA dephthalylation step utilizing a novel enzyme, o-phthalyl amidase, was developed. This step was part of a potentially new large scale synthetic route for a novel beta-lactam antibiotic Loracarbef. The enzyme was isolated from the organism Xanthobacter agilis. Purification of the enzyme to near homogeneity was accomplished by a 3-step procedure. Studies indicated that the phthalimido group can be opened chemically to generate the o-phthalyl derivative. This enzyme then can remove the phthalyl group from o-phthalylated amides. Optimization of the process was achieved by combining these two hydrolysis steps. Conversion yields of 85–97.8% (mol/mol) were obtained from reactions at substrate concentrations of 5–10% (w/v).


Journal of Molecular Catalysis B-enzymatic | 1996

Discovery, purification, and properties of o-phthalyl amidase from Xanthobacter agilis

Barbara Shreve Briggs; Adam Joseph Kreuzman; Celia A. Whitesitt; Wu-Kuang Yeh; Milton Joseph Zmijewski

Abstract A selective screen for organisms that would metabolize o -phthalyl protected beta-lactams resulted in the discovery of a Xanthobacter agilis strain that contains an o -phthalyl amidase. The low level of enzyme expression in this organism could be enhanced by growing it on medium containing o -phthalate. The enzyme was purified to near homogeneity by a 6-step procedure. The phthalyl amidase was characterized for its molecular mass, amino acid composition, internal sequences, catalytic and kinetic properties. No metal ion was required by or stimulatory to the enzyme. The amidase catalyzed conversion could be complete with a reaction stoichiometry of 1:1. The pH and temperature stability of the enzyme is improved significantly by increasing ionic strength of the buffer. The enzyme exhibits a broad substrate specificity for o -phthalylated amides; however, it demonstrates an absolute requirement for the o -phthalyl protecting group. The broad substrate acceptance, high catalytic activity, and stability at high salt or substrate concentration of the enzyme indicates that it can serve as a gentle method for deprotecting phthalimido and o -phthalyl protected amides in new chemo-enzymatic synthetic routes.


Fems Microbiology Letters | 1989

Biosynthesis of vancomycin: identification of TDP-glucose: aglycosyl-vancomycin glucosyltransferase from Amycolatopsis orientalis

Milton Joseph Zmijewski; Barbara Shreve Briggs


The Journal of Antibiotics | 1998

Enzymatic deacylation of teicoplanin followed by reductive alkylation: synthesis and antibacterial activity of new glycopeptides.

Nancy June Snyder; Robin D. G. Cooper; Barbara Shreve Briggs; Milton Joseph Zmijewski; Deborah L. Mullen; Raymond E. Kaiser; Thalia I. Nicas


Archive | 1995

Process for preparation of benzo(b)thiophene glucuronides

Barbara Shreve Briggs; Milton Joseph Zmijewski


Journal of Natural Products | 1989

Biotransformation of Vancomycin B to Vancomycin Hexapeptide by a Soil Microorganism

Milton Joseph Zmijewski; Robert M. Logan; Gary G. Marconi; Manuel Debono; R. Michael Molloy; Fred Chadwell; Barbara Shreve Briggs


Archive | 2002

Stereoselective process for producing intermediates of cryptophycins

James Abraham Aikins; Barbara Shreve Briggs; Tony Y. Zhang; Milton Joseph Zmijewski


Archive | 1995

ENZYME FROM MICROBIAL SOURCE: PHTHALYL AMIDASE

Barbara Shreve Briggs; Milton Joseph Zmijewski

Collaboration


Dive into the Barbara Shreve Briggs's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge